3-hydroxyflavone has been researched along with Lung Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, HX; Lou, HX; Shen, T; Wang, T; Wang, XN; Wu, XY; Zhang, K; Zhao, BB; Zhao, Y | 1 |
1 other study(ies) available for 3-hydroxyflavone and Lung Diseases
| Article | Year |
|---|---|
The alleviative effect of flavonol-type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders.
Topics: Animals; Flavonoids; Flavonols; Inflammation; Kelch-Like ECH-Associated Protein 1; Lung Diseases; Mice; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Physalis | 2022 |